MORRISTOWN, N.J., June 9, 2011 /PRNewswire/ — Dr. Lowell S.
Kabnick, MD, RPhS, FACS, FACPh, Director of NYU Vein Center and
internationally recognized authority and pioneer in the field of
vascular surgery, is once again leading the way with breakthrough
techniques, being the first in the country to use the new
VenaCure® 1470nm laser to treat varicose veins. The new laser
uses a lower power output compared with other lasers resulting in
effective vein closure.
The VenaCure 1470nm laser’s light energy is accurately delivered
through the NeverTouch® gold-tip fiber, and is more readily
absorbed by the water in the blood and endothelial lining than with
other wavelengths. The specially engineered fiber tip has a low
power density that maximizes effectiveness and minimizes
postoperative pain and bruising. The VenaCure 1470nm lasers are
manufactured in AngioDynamics’ Cambridge, U.K., facility, and have
received the CE mark and 510k clearance.
Ongoing research studies have found excellent vein closure
rates, minimal postoperative discomfort and bruising, and a clear
reduction in symptom severity over the follow-up period.
“The 1470nm laser enables us to be more efficient during a
procedure, we are able to treat veins much more efficiently, which
ultimately improves the patients procedure experience,” stated Dr.
Kabnick. “That translates into quicker recovery for patients.”
About Lowell S. Kabnick, MD, RPhS, FACS, FACPh
Lowell S. Kabnick, MD, RPhS, FACS, FACPh, a New York University
Surgeon with offices in Manhattan and Morristown, NJ and Director
of NYU Vein Center, is a world-renowned surgeon-teacher whose
patient-centered approach to vein care has enabled the creation and
improvement of many of today’s most advanced noninvasive vascular
surgery techniques. Recognized by his peers as an international
leader in the diagnosis and treatment of venous disease, Dr.
Kabnick was the first vascular surgeon in the United St
‘/>”/>
